Geode Capital Management
ENFN

Geode Capital Management’s Enfusion, Inc. ENFN Stock Holding History

Geode Capital Management’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,093,229
Closed -$12.2M – 4555
2025
Q1 		$12.2M Buy
1,093,229
+42,680
+4% +$472K ﹤0.01% 2167
2024
Q4 		$10.8M Buy
1,050,549
+21,183
+2% +$205K ﹤0.01% 2327
2024
Q3 		$9.77M Buy
1,029,366
+70,367
+7% +$607K ﹤0.01% 2391
2024
Q2 		$8.17M Buy
958,999
+143,907
+18% +$1.32M ﹤0.01% 2449
2024
Q1 		$7.54M Buy
815,092
+35,402
+5% +$311K ﹤0.01% 2494
2023
Q4 		$7.56M Buy
779,690
+56,267
+8% +$526K ﹤0.01% 2483
2023
Q3 		$6.49M Buy
723,423
+298,806
+70% +$2.84M ﹤0.01% 2504
2023
Q2 		$4.76M Buy
424,617
+52,783
+14% +$468K ﹤0.01% 2708
2023
Q1 		$3.9M Buy
371,834
+23,104
+7% +$255K ﹤0.01% 2746
2022
Q4 		$3.37M Buy
348,730
+11,533
+3% +$130K ﹤0.01% 2857
2022
Q3 		$4.16M Sell
337,197
-52,113
-13% -$636K ﹤0.01% 2765
2022
Q2 		$3.97M Buy
389,310
+50,481
+15% +$558K ﹤0.01% 2822
2022
Q1 		$4.31M Buy
338,829
+12,403
+4% +$189K ﹤0.01% 2882
2021
Q4 		$6.83M Buy
+326,426
New +$6.6M ﹤0.01% 2706

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Geode Capital Management's ENFN Position: Q2 2025 in Review

Geode Capital Management sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 1,093,229 shares — an estimated $12.2M sold.

Geode Capital Management first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $12.2M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Geode Capital Management reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Geode Capital Management sold 1,093,229 Enfusion, Inc. shares in Q2 2025, an estimated $12.2M.
  • Geode Capital Management first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • Geode Capital Management's Enfusion, Inc. position peaked at $12.2M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.